In this video, Melanie Leveridge, Head of Screening, Profiling and Mechanistic Biology at GlaxoSmithKline (GSK), Stevenage, UK, discusses her team’s goal of reducing overall cycle times in early drug discovery. Leveridge explains how her team closely collaborated with TTP Labtech in the design and development of the dragonfly® discovery liquid handling system that has accelerated assay development time.